Tumor metastasis, recurrence, and therapeutic resistance are the main reasons for the failure of clinical cancer treatment. Studies have found that ...

In a paper published in National Science Review, an international team of scientists report a coordination nanomedicine ...

Vimentin is a type III intermediate filament (IF) protein typically expressed in cells that differentiate into connective ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.

New research has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth.

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...